Price target
338.600.00 0.00%
The 2 analysts offering 1 year price forecasts for BLRX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to BLRX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
BLRX EPS for the last quarter is −0.05 ILA despite the estimation of −0.05 ILA. In the next quarter EPS is expected to reach −0.07 ILA. Track more of BIOLINE RX financials and stay on top of what is up with the company.
In the next quarter BIOLINE RX revenue is expected to reach 1.26 M ILA. Check out BIOLINE RX revenue and earnings and make informed decisions.
According to analysts, BLRX price target is 338.60 ILA with a max estimate of 517.13 ILA and a min estimate of 160.06 ILA. Check if this forecast comes true in a year, meanwhile keep track of the current situation with BLRX news and stock market news.